Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers (ECO-THYR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03787121|
Recruitment Status : Recruiting
First Posted : December 25, 2018
Last Update Posted : July 11, 2019
The incidence of Thyroid Cancer (TC) has increased over the last thirty years, in France and worldwide. This increase is mainly due to good prognosis microPapillary TC (mPTC). Sixty percent of diagnosed cancers are considered as over-diagnosed, leading to an over-treatment of these cases. The increase of diagnosis of mPTC and its treatment inevitably leads to an increase of medical resources consumption and corresponding costs.
The primary aim of this study is to estimate the cost related to different care management pathway of TC patient during a lifetime period using a multi-state Markov model.
This is a retrospective, observational population based cohort study, using data from a cohort study of TC patients implemented by the ONCOMIP network which initially aimed to perform an audit of clinical practices for the management of TC, and from database of the French social health insurance of Midi-Pyrenees region to calculate observed costs of TC management during 24 months.
|Condition or disease||Intervention/treatment|
|Thyroid Cancer||Procedure: care management pathways|
|Study Type :||Observational|
|Estimated Enrollment :||423 participants|
|Official Title:||Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers : Involvement of Overtreatment|
|Actual Study Start Date :||April 1, 2019|
|Estimated Primary Completion Date :||December 2021|
|Estimated Study Completion Date :||December 2021|
- Procedure: care management pathways
different care management pathways, including thyroidectomy, iode 131, hormonal treatment and type of follow up
- cost related to the different management pathways of TC patient [ Time Frame: 24 months ]estimate the cost related to the different management pathways of TC patient during a lifetime period using a multi-state Markov model
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03787121
|Contact: Nadège Costa, PhDfirstname.lastname@example.org|
|Contact: Nadège Costa, PhD|
|Principal Investigator:||Nadège Costa, PhD||University Hospital, Toulouse|